Catalent Pharma Solutions, Inc. Submits Notice of Registration for Controlled Substance Manufacturing Operations

Summary

Catalent Pharma Solutions, Inc. has submitted a notice of registration with the U.S. Drug Enforcement Administration (DEA) for its controlled substance manufacturing operations. The company is required to register with the DEA under the Controlled Substances Act.